Sector ratings Grifols, S.A.

Equities

Market Closed - BME Other stock markets 11:36:21 2026-01-15 am EST			5-day change	1st Jan Change
11.21 ^EUR	-3.98%		-3.28%	+4.77%

Jan. 15	European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading	MT
Jan. 14	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
GRIFOLS, S.A.	8.18B		BB
REGENERON PHARMACEUTICALS, INC.	77.37B		A
SAMSUNG BIOLOGICS CO.,LTD.	60.9B		BBB
UCB	57.48B		AA
CSL LIMITED	55.92B		AA
BIOGEN INC.	24.84B		AA
INCYTE CORPORATION	20.8B		AA
INNOVENT BIOLOGICS, INC.	19.9B		AAA
ALTEOGEN INC.	17.05B		CCC
MODERNA, INC.	15.86B	-	A	-		-
BRIDGEBIO PHARMA, INC.	15.01B	-	BB	-		-
INTRA-CELLULAR THERAPIES, INC.	14.02B	-	BBB	-		-	-
SWEDISH ORPHAN BIOVITRUM AB	12.81B		AA
AVIDITY BIOSCIENCES, INC.	10.93B	-	BB	-		-
BIOMARIN PHARMACEUTICAL INC.	10.77B		BBB
3SBIO INC.	8.75B		AA
AXSOME THERAPEUTICS, INC.	8.92B	-	BB	-		-
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	8.59B	-	B	-		-	-
KRYSTAL BIOTECH, INC.	8.46B		B			-
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.	7.8B	-	-	-	-	-	-	-
Average	23.22B		A
Weighted average by Cap.			A